References
- Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172–187.
- Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021. Gastroenterol. 2022;162(2):621–644.
- Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024.
- Leproult R, Cauter V. E. Role of sleep and sleep loss in hormonal release and metabolism. Endocr Dev. 2010;17:11–21.
- The national academies collection: reports funded by national institutes of health. In: Colten HR, Altevogt BM, editors. Sleep disorders and sleep deprivation: an unmet public health problem. Washington (DC): National Academies Press (US), National Academy of Sciences; 2006.
- Papatheodoridi M, Cholongitas E. Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts. Curr Pharm Des. 2018;24(38):457–486.
- Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–S90.
- Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57(10):1441–1447.
- Rico-Martín S, Calderón-García JF, Sánchez-Rey P, et al. Effectiveness of body roundness index in predicting metabolic syndrome: a systematic review and meta-analysis. Obes Rev. 2020;21(7):e13023.
- Shen J, Zhou H, Liu J, et al. A modifiable risk factors atlas of lung cancer: a mendelian randomization study. Cancer Med. 2021;10(13):4587–4603.
- Kamat MA, Blackshaw JA, Young R, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851–4853.
- Bull CJ, Bonilla C, Holly JM, et al. Blood lipids and prostate cancer: a mendelian randomization analysis. Cancer Med. 2016;5(6):1125–1136.
- Burgess S, Thompson SG. Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–764.
- Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–698.
- Zhu G, Zhou S, Xu Y, et al. Mendelian randomization study on the causal effects of COVID-19 on childhood intelligence. J Med Virol. 2022;94(7):3233–3239.
- Tsai CJ, Leitzmann MF, Willett WC, et al. Macronutrients and insulin resistance in cholesterol gallstone disease. Am J Gastroenterol. 2008;103(11):2932–2939.
- Carey MC, Paigen B. Epidemiology of the American indians’ burden and its likely genetic origins. Hepatol. 2002;36(4 Pt 1):781–791.
- Sampliner RE, Bennett PH, Comess LJ, et al. Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med. 1970;283(25):1358–1364.
- Comess LJ, Bennett PH, Burch TA. Clinical gallbladder disease in pima indians. Its high prevalence in contrast to framingham, Massachusetts. New Engl J Med. 1967;277(17):894–898.
- Stokes CS, Krawczyk M, Lammert F. Gallstones: environment, lifestyle and genes. Digestive Dis. 2011;29(2):191–201.
- Cirillo DJ, Wallace RB, Rodabough RJ, et al. Effect of estrogen therapy on gallbladder disease. JAMA. 2005;293(3):330–339.
- Ranelletti FO, Piantelli M, Farinon AM, et al. Estrogen and progesterone receptors in the gallbladders from patients with gallstones. Hepatol. 1991;14(4 Pt 1):608–612.
- Yuan S, Gill D, Giovannucci EL, et al. Obesity, type 2 diabetes, lifestyle factors, and risk of gallstone disease: a mendelian randomization investigation. Clin Gastroenterol Hepatol. 2022;20(3):e529–e37.
- Cruz-Monserrate Z, Conwell DL, Krishna SG. The impact of obesity on gallstone disease, acute pancreatitis, and pancreatic cancer. Gastroenterol Clin N Am. 2016;45(4):625–637.
- Muhidin SO, Magan AA, Osman KA, et al. The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome. J Obesity. 2012;2012:637538.
- Di Ciaula A, Garruti G, Frühbeck G, et al. The role of diet in the pathogenesis of cholesterol gallstones. Curr Med Chem. 2019;26(19):3620–3638.
- Sun H, Warren J, Yip J, et al. Factors influencing gallstone formation: a review of the literature. Biomol. 2022;12(4):550.
- Churg A, Dai J, Tai H, et al. Tumor necrosis factor-alpha is Central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med. 2002;166(6):849–854.
- Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res. 2012;91(2):142–149.
- Rigotti NA, Clair C. Managing tobacco use: the neglected cardiovascular disease risk factor. Eur Heart J. 2013;34(42):3259–3267.
- Biddinger SB, Haas JT, Yu BB, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nature Med. 2008;14(7):778–782.
- Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230–239.
- Zhang YP, Zhao YL, Sun YL, et al. Physical activity and the risk of gallstone disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2017;51(9):857–868.
- Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obesity Res. 2004;12(5):789–798.
- Seals DR, Hagberg JM, Hurley BF, et al. Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women. JAMA. 1984;252(5):645–649.
- Utter AC, Whitcomb DC, Nieman DC, et al. Effects of exercise training on gallbladder function in an obese female population. Med Sci Sports Exer. 2000;32(1):41–45.
- Wilund KR, Feeney LA, Tomayko EJ, et al. Endurance exercise training reduces gallstone development in mice. J Appl Physiol. 2008;104(3):761–765.
- Philipp E, Wilckens T, Friess E, et al. Cholecystokinin, gastrin and stress hormone responses in marathon runners. Peptides. 1992;13(1):125–128.